Oura Eyes September IPO With Valuation Exceeding $16 Billion
Smart ring maker Oura plans to raise up to $3 billion in a U.S. IPO next month, targeting a valuation north of $16 billion amid a booming wearables market.
Stock photo for illustration only, not from the actual event
- Oura is reportedly preparing for a U.S. IPO in September 2026.
- The company aims to raise up to $3 billion with a valuation exceeding $16 billion.
- Revenue grew from $500 million in 2024 to an expected $2 billion in 2026.
- Oura faces a class-action lawsuit over sleep-tracking accuracy claims.
Oura, the San Francisco and Finland-based smart ring manufacturer, is reportedly preparing to launch a U.S. initial public offering as early as next month, targeting a fundraising goal of up to $3 billion. According to reports from Bloomberg, the 900-employee company could achieve a valuation north of $16 billion in the offering, with investors expected to sell a substantial portion of their stock holdings.
A $16 billion valuation represents a massive leap from the $10.9 billion valuation assigned to Oura last September. During that funding round, the company closed an $875 million Series E backed by prominent financial institutions such as Fidelity, ICONIQ, Whale Rock, and Atreides, alongside returning investors like Dexcom, The Chernin Group, Forerunner Ventures, Coatue, and Temasek.
Stock photo for illustration only, not from the actual event
The consumer wearables sector has experienced rapid crowding and intense competition. Samsung introduced its Galaxy Ring two years ago, while Oura's primary rival, Whoop, has aggressively reinvented its product strategy. Originally serving elite athletes and young demographics, Whoop expanded its market reach over the past year by introducing hormone tracking and blood-panel testing aimed at perimenopause and thyroid health, pushing its valuation to $10 billion in March. Similarly, Oura has evolved from its niche origins among biohacking tech executives into a mainstream wellness brand focused on sleep and physiological recovery.
Oura previously announced that it filed confidentially for an IPO back in May. The company reported generating $500 million in revenue during 2024, scaling to roughly $1 billion in 2025, and projecting close to $2 billion in revenue for 2026. Comprehensive financial details will become publicly accessible once the company's S-1 registration statement is officially released.
Oura's push toward public markets highlights the surging consumer demand for continuous biometric monitoring and preventative health management. However, as wearable technology matures into mainstream healthcare and fitness spaces, companies face heightened scrutiny regarding the scientific validity of their proprietary algorithms. Navigating regulatory expectations and consumer trust will remain critical factors for smart ring manufacturers scaling beyond their original tech-enthusiast user bases.
Despite its financial momentum, Oura's recent public attention has not been entirely favorable. A proposed class-action lawsuit filed in San Francisco accuses the company of misleading consumers regarding the scientific accuracy of its sleep-tracking features. The legal filing specifically claims that Oura promotes its ability to measure exact sleep stages—a clinical assessment that typically requires scalp electrodes and eye sensors found strictly within medical and hospital environments.
Source: TechCrunch
Found something wrong in this article? Report an issue with this article
Comments
Leave a Comment